JP2021510815A5 - - Google Patents

Download PDF

Info

Publication number
JP2021510815A5
JP2021510815A5 JP2020538662A JP2020538662A JP2021510815A5 JP 2021510815 A5 JP2021510815 A5 JP 2021510815A5 JP 2020538662 A JP2020538662 A JP 2020538662A JP 2020538662 A JP2020538662 A JP 2020538662A JP 2021510815 A5 JP2021510815 A5 JP 2021510815A5
Authority
JP
Japan
Prior art keywords
protein
light chain
free light
periodontitis
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020538662A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021510815A (ja
JP7330983B2 (ja
Filing date
Publication date
Priority claimed from EP18151839.0A external-priority patent/EP3511716A1/en
Application filed filed Critical
Publication of JP2021510815A publication Critical patent/JP2021510815A/ja
Publication of JP2021510815A5 publication Critical patent/JP2021510815A5/ja
Priority to JP2023110445A priority Critical patent/JP2023134563A/ja
Application granted granted Critical
Publication of JP7330983B2 publication Critical patent/JP7330983B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020538662A 2018-01-16 2019-01-09 歯周炎の診断方法、使用及びキット Active JP7330983B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023110445A JP2023134563A (ja) 2018-01-16 2023-07-05 歯周炎の診断方法、使用及びキット

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18151839.0 2018-01-16
EP18151839.0A EP3511716A1 (en) 2018-01-16 2018-01-16 Periodontitis diagnostic methods, uses and kits
PCT/EP2019/050364 WO2019141547A1 (en) 2018-01-16 2019-01-09 Periodontitis diagnostic methods, uses and kits

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023110445A Division JP2023134563A (ja) 2018-01-16 2023-07-05 歯周炎の診断方法、使用及びキット

Publications (3)

Publication Number Publication Date
JP2021510815A JP2021510815A (ja) 2021-04-30
JP2021510815A5 true JP2021510815A5 (enExample) 2022-01-04
JP7330983B2 JP7330983B2 (ja) 2023-08-22

Family

ID=61131917

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020538662A Active JP7330983B2 (ja) 2018-01-16 2019-01-09 歯周炎の診断方法、使用及びキット
JP2023110445A Pending JP2023134563A (ja) 2018-01-16 2023-07-05 歯周炎の診断方法、使用及びキット

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023110445A Pending JP2023134563A (ja) 2018-01-16 2023-07-05 歯周炎の診断方法、使用及びキット

Country Status (7)

Country Link
US (1) US20210063412A1 (enExample)
EP (2) EP3511716A1 (enExample)
JP (2) JP7330983B2 (enExample)
CN (1) CN111630389B (enExample)
CA (1) CA3088339A1 (enExample)
RU (1) RU2020127365A (enExample)
WO (1) WO2019141547A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3553523A1 (en) * 2018-04-12 2019-10-16 Koninklijke Philips N.V. Diagnostics of mild or advanced periodontitis
EP3553520A1 (en) * 2018-04-12 2019-10-16 Koninklijke Philips N.V. Methods, uses and kits for monitoring or predicting response to periodontal disease treatment
WO2022096893A1 (en) 2020-11-04 2022-05-12 The University Of Birmingham Device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179606B2 (en) * 2001-11-23 2007-02-20 Syn X Pharma, Inc. IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease
CN101523218B (zh) * 2006-09-29 2014-07-09 霍夫曼-拉罗奇有限公司 评估类风湿性关节炎患者疾病进展的风险
US8728744B2 (en) * 2007-10-26 2014-05-20 The Regents Of The University Of California Salivary protein biomarkers for human oral cancer
CN102460174B (zh) * 2009-05-14 2016-03-16 牛津大学之校长及学者 使用一组新型低丰度人类血浆蛋白生物标记对肝纤维化进行临床诊断
WO2010151789A1 (en) * 2009-06-25 2010-12-29 The Regents Of The University Of California Salivary transcriptomic and microbial biomarkers for pancreatic cancer
WO2011133770A2 (en) * 2010-04-21 2011-10-27 Board Of Regents Of The University Of Texas System Salivary protein markers for detection of breast cancer
JP5869323B2 (ja) * 2011-12-01 2016-02-24 花王株式会社 歯周病マーカー
EP3396383A1 (en) * 2012-09-10 2018-10-31 Koninklijke Philips N.V. Analysis of saliva proteome for biomarkers of gingivitis and periodontitis using ft-icr-ms/ms
WO2015087985A1 (ja) * 2013-12-11 2015-06-18 株式会社資生堂 腎不全の早期診断マーカー
CA2971517A1 (en) * 2014-12-19 2016-06-23 Universite De Nantes Anti il-34 antibodies
GB201708262D0 (en) * 2017-05-23 2017-07-05 Binding Site Group Ltd Assay for plasma cell associated disease

Similar Documents

Publication Publication Date Title
Penny et al. Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult cohorts
Langhorst et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices
Skupien et al. Patterns of estimated glomerular filtration rate decline leading to end-stage renal disease in type 1 diabetes
RU2020127440A (ru) Способы, применения и наборы для диагностики заболеваний периодонта
JP2019530875A5 (enExample)
Covin et al. Measurement and clinical applications of C‐reactive protein in gastrointestinal diseases of dogs
Lammi et al. Antibodies to deamidated gliadin peptide in diagnosis of celiac disease in children
Salgado et al. Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension
JP2021510815A5 (enExample)
RU2019143570A (ru) Диагностика периодонтита на основании hgf и mmp-8 в слюне
Porcelli et al. Assessment of a test for the screening and diagnosis of celiac disease
Ji et al. Diagnostic and prognostic value of galectin‐3, serum creatinine, and cystatin C in chronic kidney diseases
CN104977421B (zh) 临床样本自动分析仪器以及分析方法
JP2018536170A5 (enExample)
RU2020127365A (ru) Способы, применения и комплекты для диагностики пародонтита
Montanes Bermudez et al. Consensus document. Recommendations on assessing proteinuria during the diagnosis and follow-up of chronic kidney disease
Wentworth et al. Islet autoantibody screening throughout Australia using in-home blood spot sampling: 2-year outcomes of Type1Screen
Niwaha et al. HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study
Abel et al. Analytical validation and performance of a blood-based P-tau217 diagnostic test for Alzheimer disease
Katsoulos et al. Evaluation of a portable glucose meter for use in cattle and sheep
Bottomley et al. Single estimated glomerular filtration rate and albuminuria measurement substantially overestimates prevalence of chronic kidney disease
Morohashi et al. β2‐microglobulin measurement with dried urine spots for congenital anomalies of the kidney and urinary tract screening in 3‐year‐old children
CN104819981B (zh) 一种尿液成分测量仪
Kuriyama et al. Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test
Londeree et al. Bodily fluid analysis of non-serum samples using point-of-care testing with iSTAT and Piccolo analyzers versus a fixed hospital chemistry analytical platform